|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| BPH | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Urinary Bladder Neck Obstruction | |||||
| 3 | More general conditions related to this trial | ||||
| Urethral Diseases | |||||
| Urethral Obstruction | |||||
| Urinary Bladder Diseases | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| alfuzosin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Adrenergic Agents | |||||
| Adrenergic alpha-Antagonists | |||||
| Adrenergic Antagonists | |||||
| Antihypertensive Agents | |||||
| Cardiovascular Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Asan Medical Center | |||||